Mucosal administration of pneumococcal antigens

Details Mucosal administration of pneumococcal antigens Mucosal administration of pneumococcal antigens

A - Human Necessities

61

K

A61K 39/02 (2006.01) C07K 14/315 (2006.01) C07K 14/715 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2149703

Mucosal administration, particularly intranasally, of killed whole pneumococci, lysate of pneumococci and isolated and purified PspA, as well as immunogenic fragments thereof, particularly when administered with cholera toxin B subunit, provides protection in animals against pneumococcal colonization and systemic infection. The ability to elicit protection against pneumococcal colonization in a host prevents carriage among immunized individuals, which can lead to elimination of disease from the population as a whole.

Affiliated with

Also associated with

Rating

Mucosal administration of pneumococcal antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mucosal administration of pneumococcal antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucosal administration of pneumococcal antigens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1988269